Targeted IL-15-based Protein Fusion Complexes as Cancer Immunotherapy Approaches

Journal of Immunological Sciences
doi 10.29245/2578-3009/2018/1.1111
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Sciaccess Publishers LLC

Related search

Discovery of a Novel IL-15 Based Protein With Improved Developability and Efficacy for Cancer Immunotherapy

Scientific Reports
Multidisciplinary
2018English

High Antitumor Activity of RLI, an Interleukin-15 (IL-15)-IL-15 Receptor Fusion Protein, in Metastatic Melanoma and Colorectal Cancer

Molecular Cancer Therapeutics
Cancer ResearchOncology
2009English

Melittin-Mil-2 Fusion Protein as a Candidate for Cancer Immunotherapy

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2016English

Mesothelin Targeted Cancer Immunotherapy

European Journal of Cancer
Cancer ResearchOncology
2008English

Rational Approaches to Human Cancer Immunotherapy

Journal of Leukocyte Biology
AllergyImmunologyCell Biology
2003English

Prospects of IL-2 in Cancer Immunotherapy

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2018English

Fusion Protein, DNAJB1-PRKACA, as a Cancer Driver

Biophysical Journal
Biophysics
2017English

Cell-Based Immunotherapy Approaches for Multiple Myeloma

British Journal of Cancer
Cancer ResearchOncology
2018English

P28-Fur-Grb, a Novel Fusion Protein With Enhanced Targeted Cytotoxicity Against Breast Cancer

Clinical Oncology and Research
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy